Parasitic Gastroenteritis (1 Challenge) EQA/PT Scheme

Parasites are a frequent cause of gastroenteritis and are a growing risk in this age of global travel. The panel members of this EQA will resemble clinical samples and may include current clinically relevant strains of Giardia, Cryptosporidium, Dientamoeba, Blastocystis and Entamoeba. The aim of the Parasitic Gastroenteritis EQA is to assess laboratories’ ability to detect a range of parasitic pathogens known to cause gastroenteritis using their routine molecular diagnostic platform and procedures.

Total Number of Challenges: 1
Number of Panel Members: 10
Distribution / Testing Period: Q4
Sample NA Target Source Cultured material and/or Clinical material
Matrix Panel Format Synthetic Faecal Matrix and/or Transport Medium
Panel Member Target Range Covering Clinical Range
Panel Member Sample Volume 1.0 ml
Panel Sample Pre-treatment Requirement Ready for analysis. Pre-treatment may be required for SFM. Follow test manufacturer’s IFU.
Panel Analysis Type Qualitative
Panel Testing Evaluated by various molecular methodologies
Storage / Shipment Conditions <-20°C / Frozen on Dry-ice
Accreditation / Regulatory Status Accredited to ISO 17043

$1,275.73